Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02173444

Acronym

AMH FSH AFC

Enrollment

820

Registered

2014-06-25

Start date

2013-01-31

Completion date

Unknown

Last updated

2014-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

in-vitro fertilization, ovarian stimulation

Brief summary

Serum bio-markers have different prediction values for ovarian response during ovarian stimulation in-vitro fertilization

Interventions

OTHERBlood test

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Age ≤ 45 years at the time of FSH starting * BMI \< 25 kg/m2, * First IVF attempt * Receiving GnRH-antagonist protocol * Had oocyte retrieval

Exclusion criteria

* Had ovarian stimulation or ovulation induction within 2 months prior to the study * PCOS * Had ovarian tumor or endometrioma * Hyperprolactinemia * Thyroid hormone disorders * Pituitary failure * Had other medical situations such as liver failure, renal failure, heart disease, diabetes, depression * Had IVM

Design outcomes

Primary

Measure	Time frame
Number of oocytes	At the time of oocyte retrieval
number of oocytes at time of oocyte retrieval	up to 14 days

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026